Albania: Medical and Donor Requirements for Assisted Reproduction in Surrogacy Arrangements
The decision in brief
Albanian Law No. 8876 of 4 April 2002 contains rules on assisted medical reproduction: eligibility conditions, indications, written consent, professional licensing, the use of gametes, and limits on embryo use. It is not a complete, operational surrogacy code. A clinic's willingness to transfer an embryo, or an agency's description of an available programme, does not establish that every donor, carrier and intended-parent arrangement is legally authorised. Before paying or starting medication, identify who provides the egg and sperm, who carries the pregnancy, what procedure is planned, and which binding text the provider says covers each role. [S1,S2,S3]
Which sources govern, and what is still uncertain?
The principal published legislative text reviewed here is Law No. 8876 on Reproductive Health, as reproduced in Albanian with reference to a 2009 amendment; an English translation of the 2002 text is also available, but is not an authenticated current consolidation. Articles 30–41 address assisted-reproduction techniques; Article 43 calls for separate ministerial specifications, including for ‘surrogate adoption’. The Family Code (Law No. 9062 of 8 May 2003), Article 261, refers surrogate adoption to the ordinary adoption criteria and procedures. Neither reference alone supplies a verified operating permit for a particular gestational-carrier programme or automatic recognition of intended parents. [S1,S2,S3]
What medical entry conditions appear in the law?
Article 32 refers to reaching marriageable age; for spouses it describes two years of unsuccessful attempts to have a child before embryo transfer or insemination; it also requires a licensed specialist doctor and written consent of the people concerned for each cycle. The two-year wording explicitly addresses spouses, so it must not be casually presented as a universal waiting period for every patient or foreign applicant. The text does not resolve how an intended parent who is not the treating patient or a separate gestational carrier fits each limb. Ask for the currently applicable Albanian text and a role-by-role interpretation. For context, the unofficial translation of Family Code Article 7 gives 18 as the ordinary marriage age and allows court permission for younger marriages in some cases; that marriage exception is not itself permission to undergo assisted reproduction. [S1,S2,S3]
Which indications must clinicians assess?
Under Article 33, the statutory grounds include infertility treatment where other approaches are ineffective or unsuitable, prevention of transmission of serious genetic or other disease, and an alternative to natural childbirth. Article 41 separately identifies examples for in-vitro fertilisation: damage or defects of the woman's fallopian tubes, male infertility or serious genetic disease, and sperm unsuitable for natural conception. These are legal descriptions, not a doctor's conclusion that a specific person is suitable for stimulation, retrieval, transfer, pregnancy or childbirth. Obtain a clinical indication for the actual procedure, not merely an agency's statement that infertility evidence is ‘unnecessary’. [S1,S2]
Consent belongs to each affected person
Articles 9 and 20 protect the individual's reproductive choice and require agreement in the use of reproductive technologies. Article 32 requires written consent for each cycle; Article 40 requires written consent from the woman supplying eggs and the man supplying sperm for the IVF procedure described there. The person carrying the pregnancy must separately and freely consent to procedures performed on her; a contract signed by intended parents does not replace her medical consent. Verify when consent may be withdrawn, who explains complications, how interpretation is provided and whether separate consent forms cover retrieval, fertilisation, cryostorage and embryo transfer. The latter form-by-form checklist is risk-management advice, not an assertion that every form is prescribed by Article 32. [S1,S2]
Donor sperm, donor eggs and genetic links
Article 34 expressly describes artificial insemination using semen from a donor other than the woman's spouse in the stated context. Article 40 describes IVF using the eggs and sperm of a couple and requires those contributors' written agreement. Those different descriptions must not be conflated into a blanket statutory approval for every third-party egg-donation, embryo-donation, mixed-donor or surrogacy configuration. The reviewed accessible texts do not establish a complete binding donor-selection framework: age bands, anonymity, quotas, cross-border import, compensation, infectious-disease panels and genetic screening require current subordinate legislation and provider-specific verification. A clinical donor-screening protocol is not automatically a legal rule. [S1,S2]
Storage and embryo-use restrictions
Article 39 recognises the right of men and women to preserve gametes and provides for ministerial rules on the conditions of storage and use. Article 36 likewise delegates details for assisted technologies. Article 37 prohibits selecting a future child's sex, with an exception where there is a possibility of inheriting a sex-linked disease. Article 38 restricts use of the human embryo for other commercial, industrial or experimental purposes. The embryo provision must not be distorted into a conclusion that all fertility treatment is prohibited, or that every payment connected with donation or surrogacy is expressly lawful or unlawful. Ask for the exact storage, disposal, transport and payment provisions applicable to the clinic's proposal. [S1,S2]
A gestational carrier needs her own assessment
Medical screening should cover the prospective carrier's obstetric history, pregnancy risks, infectious-disease testing, capacity to make voluntary decisions, counselling and independent clinical advice; the treating physician must determine the actual examinations. Law No. 8876 protects the pregnant woman's autonomy and care, but the reviewed text does not confirm a generally binding carrier age of 25, a prior-live-birth requirement, or a categorical ban on using the carrier's own eggs under the current law. Do not announce those figures as current Albanian eligibility criteria. Separately check carrier consent, medical insurance, pregnancy and delivery planning, and what happens if a doctor advises against transfer. [S1,S2,S4]
The 2024 reform proposal is not a current checklist
The Ministry of Health posted a Sexual and Reproductive Health bill for public consultation on 18 April 2024; the consultation closed on 16 May 2024. That consultation notice does not authenticate a binding rule requiring a carrier to be over 25, to have given birth before, or to use no eggs of her own, nor a binding requirement that an intended mother be medically unable to carry a pregnancy. Claims about those criteria need an exact adopted provision and its commencement date, not a draft summary or agency brochure. In March 2025 Albania’s delegation told a UN committee the bill was still being examined by the government. Adoption or commencement by October 2026 has not been independently established. Do not treat the proposal as current law without the adopted official text, publication and effective date. [S4,S5]
Law versus clinic policy: the verification matrix
Classify each question before choosing a provider. The law column below reflects the reviewed texts, not a definitive opinion that no other ministerial or later instrument exists. A clinic must identify the provision or medical protocol it actually applies; a marketing FAQ is insufficient. [S1,S2,S3,S4]
| Issue | What the reviewed law says | What still needs checking |
|---|---|---|
| Entry age and attempts | Article 32: marriageable age; two unsuccessful years specified for spouses; Family Code Article 7: ordinarily 18; a court exception for marriage does not itself authorise ART | Current applicability to each participant and treatment stage |
| Licensed care and consent | Article 32: specialist, written agreement for every cycle; Article 9: voluntary intervention | Named licence, who signs which consent, withdrawal procedure |
| Donor semen | Article 34 addresses non-spousal donor semen for insemination | Donor screening, origin, traceability and lawful specific configuration |
| Eggs and IVF | Article 40 describes couple's gametes and contributors' written agreement | Third-party donor eggs, imported gametes or embryo donation |
| Storage and embryo limits | Articles 37–39: sex-selection exception, restricted other embryo uses, gamete storage | Current ministerial handling rules and contract terms |
| Carrier profile | Current carrier-specific ages/parity are not established by the reviewed text | Medical suitability, consent, current binding rules versus 2024 draft |
| Birth and parentage | Family Code Article 261 points to adoption rules, not automatic parentage | Applicable decision, registration and cross-border recognition path |
Do not confuse treatment with legal parenthood
Even where an IVF procedure is clinically practicable, legal parentage is a separate question. Article 43's mention of surrogate adoption directs ministerial rulemaking; Family Code Article 261 refers to the adoption regime. Neither proves automatic intended-parent status at birth or that a private pre-birth agreement replaces any court or administrative process. The intended parents' domicile and nationality may create additional requirements for recognition and the child's documents. This article does not decide those separate questions: secure a written Albanian-law analysis and a second opinion in the destination/home jurisdiction before conception. [S1,S3]
Evidence packet to request before signing
Ask the clinic and coordinator for: (1) the medical establishment's current licence and the responsible specialist's credentials; (2) a signed indication describing the proposed ART procedure; (3) a clear diagram naming the intended parents, egg provider, sperm provider and gestational carrier; (4) source and chain-of-custody records for all gametes or embryos; (5) screening protocols, results and lawful disclosure rules; (6) separate informed-consent forms for each participant and cycle; (7) cryostorage, transport, destruction and complication policies; and (8) a signed statement identifying every cited Albanian legislative or ministerial provision, including its date and scope. Some are prudent due-diligence documents rather than statutory documents expressly listed in Law No. 8876. [S1,S2]
A safe sequence for a proposed arrangement
First, define the participant map and intended genetic links. Second, have an Albanian lawyer verify the current law, ministerial acts, clinic licensing and donor pathway independently from the agency. Third, request the physician's indication and an individual risk assessment for the egg provider and carrier. Fourth, compare the provider's consents and donor/storage protocols against verified mandatory rules and resolve discrepancies in writing. Fifth, obtain a separate opinion about post-birth parentage, registration and recognition where the family will live. Sixth, only after the legal and medical gates are addressed should participants evaluate treatment dates, costs or agreements. A favourable consultation is not a guarantee of treatment approval or parentage. [S1,S2,S3]
If a clinic refuses, or an agency promises an exception
Request the precise reason in writing: medical risk, missing documents, internal clinic standard, licensing scope, or a particular legal prohibition. These require different responses. A clinical refusal may justify a second licensed medical opinion; a claim about a legal prohibition needs the article and its currently applicable text; a missing consent requires a lawful new decision by that participant, not substitution by a coordinator. Article 17 of Law No. 8876 recognises the ability to complain against interference with reproductive rights, but it does not itself guarantee success of any complaint or a right to force a doctor to perform a procedure. Preserve correspondence and seek local advice on the competent forum and deadlines. [S1,S2]
Two configurations illustrate the difference
Example A: a married couple uses its own gametes, has documented infertility and seeks IVF. The consent, specialist and clinical-indication provisions can be examined directly, yet a separate carrier adds unanswered legal and medical questions. Example B: an intended father proposes donor eggs, donor sperm and a gestational carrier on the basis of an agency advertisement. Articles 34 and 40 do not, by themselves, prove this whole configuration permissible, and approval of laboratory steps would not settle parentage. The examples explain a verification method, not legal opinions or claims that either arrangement has been authorised. [S1,S2,S3]
What can be concluded now?
The accessible legislative material supports concrete rules on ART consent, indications, licensed supervision, gamete storage and restrictions on sex selection and embryo use. It does not justify presenting a single complete Albanian donor-and-surrogate eligibility checklist as settled law. The decisive outstanding documents are the current official consolidated texts and any operative ministerial instruments, followed by clinic-specific clinical records and legal opinions on the actual people and gametes involved. [S1,S2,S3,S4,S5]
Sources
- S1: Law No. 8876, 4 April 2002, English translation (Legislationline/ACCORD)
- S2: Ligji nr. 8876, për shëndetin riprodhues, Albanian reproduction with 2009 amendment noted
- S3: Family Code Law No. 9062, unofficial English translation
- S4: Ministry of Health consultation on sexual and reproductive health bill, April–May 2024
- S5: UN Human Rights Committee Albania dialogue, March 2025
